Open Journal of Obstetrics and Gynecology

Volume 11, Issue 11 (November 2021)

ISSN Print: 2160-8792   ISSN Online: 2160-8806

Google-based Impact Factor: 0.37  Citations  h5-index & Ranking

Uterine Arteriovenous Malformations: Therapeutic Strategies and the Place of Hysteroscopy

HTML  XML Download Download as PDF (Size: 1959KB)  PP. 1565-1580  
DOI: 10.4236/ojog.2021.1111146    189 Downloads   1,352 Views  

ABSTRACT

Uterine arteriovenous malformations (UAVMs) are not common and are not well known. They are mainly manifested by hemorrhages that can be life-threatening. Their diagnosis is based mainly on ultrasound coupled with Doppler flow, as well as pelvic magnetic resonance imaging and angiography. In the absence of a consensus, and based on our experience, we discuss the place of hysteroscopy in the therapeutic strategy of UAVM. We reported 3 cases of UAVM, and we performed a review of the literature concerning the diagnosis and treatment of this pathology. We finally collected the advantages of the embolization-hysteroscopy sequence. In fact, the data suggest that hysteroscopy is a feasible and safe alternative treatment modality for UAVM. We believe that the resection of UAVM can be done under optimal conditions with a reduced risk of bleeding. Hysteroscopy would allow for optimal evaluation of the uterine cavity after treatment as well as the possibility of applying an anti-adhesive gel. In addition, the combination of hysteroscopy and embolization would require less healing time and shorter follow-up than embolization alone. It could also reduce the number of patients lost to follow-up.

Share and Cite:

Haddout, S. , Agman, A. and Ceccaldi, P. (2021) Uterine Arteriovenous Malformations: Therapeutic Strategies and the Place of Hysteroscopy. Open Journal of Obstetrics and Gynecology, 11, 1565-1580. doi: 10.4236/ojog.2021.1111146.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.